Form 4: ICU Medical COO Christian Voigtlander Executes Stock Options and Sells Shares Under Pre-Arranged Plan

ICU Medical's Chief Operating Officer, Christian B. Voigtlander, engaged in a series of transactions involving the exercise of stock options and subsequent sale of common stock on May 27 and May 28, 2025, under a Rule 10b5-1 trading plan.

Summary

• On May 27, 2025, Christian B. Voigtlander, COO of ICU Medical Inc. (ICUI), acquired 5,555 shares of common stock by exercising non-qualified stock options at an exercise price of $96.83 per share.
• Immediately following the option exercise on May 27, 2025, Mr. Voigtlander disposed of 4,945 shares of common stock at a price of $131.00 per share.
• After these transactions on May 27, 2025, Mr. Voigtlander directly beneficially owned 5,513 shares of common stock.
• On May 28, 2025, Mr. Voigtlander acquired an additional 5,560 shares of common stock through the exercise of non-qualified stock options, also at an exercise price of $96.83 per share.
• Subsequently on May 28, 2025, he sold 4,985 shares of common stock at a weighted average price of $128.5008 per share, with individual sales ranging from $128.50 to $128.54.
• Following all reported transactions on May 28, 2025, Mr. Voigtlander directly beneficially owned 6,088 shares of common stock.
• All reported transactions were made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer, intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While insider selling can sometimes be viewed negatively, the transactions are part of a pre-arranged 10b5-1 plan, indicating a planned liquidity event rather than a reaction to new negative information. The exercise of options also highlights the profitability for the insider.

Positives

• The exercise of stock options indicates that the options were 'in-the-money,' allowing the COO to acquire shares at a lower price ($96.83) than the market sale price ($131.00 and $128.5008), demonstrating a profitable transaction for the insider.
• The transactions were conducted under a Rule 10b5-1 pre-arranged trading plan, which suggests the sales were scheduled in advance and not based on new, undisclosed negative information about the company.

Negatives

• The sale of common stock by a Chief Operating Officer reduces the insider's direct ownership stake in the company, which can sometimes be perceived negatively by investors, although mitigated by the 10b5-1 plan.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May view the insider selling with slight caution, though the pre-arranged nature (10b5-1 plan) suggests it's not based on new negative information and is a common practice for executive compensation.
• Employees: No direct impact on employees is indicated by this filing.

Key Dates

Recommendation

Keywords

ICU Medical, ICUI, SEC Form 4, Insider Trading, Stock Option Exercise, Common Stock Sale, Christian B. Voigtlander, Chief Operating Officer, 10b5-1 Plan